cdk4/6 inhibitors: changing the treatment landscape
Published 6 years ago • 195 plays • Length 3:19Download video MP4
Download video MP3
Similar videos
-
4:35
hr breast cancer: differences between cdk4/6 inhibitors
-
2:11
the use of frontline cdk4/6 inhibitors endocrine therapy in metastatic breast cancer
-
3:33
cdk 4/6 inhibitors in metastatic breast cancer
-
7:40
cdk4/6 inhibitors in the first-line treatment setting
-
8:42
hr mbc: treatment after progression on cdk4/6 inhibition
-
3:21
benefits and challenges of cdk4/6 inhibitors
-
1:17:18
changing standards of care for use of cdk4 and 6 inhibitors in the treatment of breast cancer
-
9:18
clinical experience: cdk4/6 inhibitors in breast cancer
-
5:34
considerations for treating patients with cdk4/6 inhibitors
-
4:54
monarch 3 study: cdk4/6 inhibitors in the treatment of metastatic breast cancer
-
5:57
cdk4/6 inhibitors in the second-line treatment setting
-
5:50
the efficacy and safety of cdk4/6 inhibitors
-
5:01
cdk4/6 inhibitors: sequencing endocrine therapy for metastatic breast cancer
-
3:04
optimizing cdk4/6 inhibition in hr breast cancer
-
4:45
cdk4/6 inhibitors for hr metastatic breast cancer
-
3:27
metastatic breast cancer: cdk4/6 inhibitors
-
2:06
unmet needs and cdk4/6 inhibitors in hr /her2- early breast cancer
-
1:54
cell cycle inhibitors - cdk4/6 inhibitors
-
4:17
cdk4/6 inhibitors & endocrine therapy in breast cancer